Pubblicazioni di riferimento
Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 95: 5144, 2010.
Ferté-Delbende C, Catteau-Jonard S, Barrière P, Dewailly D. Evaluation of the ovarian reserve. J Gynecol Obstet Biol Reprod (Paris) 39 (8 Suppl 2): S27, 2010.
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci A, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16: 113, 2010.
Franchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18: 323, 2003.
Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Müllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91: 941, 2006.
Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 23: 1359, 2008.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Genro, V.K., Grynberg, M., Scheffer, J.B. et al. I livelli sierici di ormone anti-Mulleriano sono correlati negativamente all’indice di risposta follicolare (FORT) in donne normali sottoposte ad iperstimolazione ovarica controllata. L’Endocrinologo 12, 95–96 (2011). https://doi.org/10.1007/BF03344797
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344797